Plasma levels of Asymmetric Di Methyl Arginine and endothelial dysfunction in diabetic subjects with neuropathic foot ulcer
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Flow-Mediated Vasodilatation and Intima-Media Thickness in Patients with Coexisting Heart Failure and Diabetes Receiving Medical TherapyDiagnostics, 2011
- Diabetic Peripheral Neuropathy Is Associated With Increased Arterial Stiffness Without Changes in Carotid Intima–Media Thickness in Type 2 DiabetesDiabetes Care, 2011
- The Pathologic Continuum of Diabetic Vascular DiseaseJACC, 2009
- Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetesNephrology Dialysis Transplantation, 2009
- A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuriaCardiovascular Diabetology, 2009
- Asymmetrical Dimethylarginine Independently Predicts Total and Cardiovascular Mortality in Individuals with Angiographic Coronary Artery Disease (The Ludwigshafen Risk and Cardiovascular Health Study)Clinical Chemistry, 2007
- Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) studyAmerican Heart Journal, 2006
- Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetesLife Sciences, 2005
- Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD responseEuropean Heart Journal, 2004
- Long-term predictors of coronary artery disease and mortality in type 1 diabetesQJM: An International Journal of Medicine, 2001